D.R. Horton, Inc.
DHI
$133.96
$4.593.55%
Weiss Ratings | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Reward Grade | B | |||
Rating Factors | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Weak | |||
Growth Index | Fair | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.00 | |||
Price History | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.40% | |||
30-Day Total Return | -8.85% | |||
60-Day Total Return | -16.15% | |||
90-Day Total Return | -25.83% | |||
Year to Date Total Return | -2.68% | |||
1-Year Total Return | -11.91% | |||
2-Year Total Return | 47.31% | |||
3-Year Total Return | 69.27% | |||
5-Year Total Return | 151.85% | |||
52-Week High % Change | -35.27% | |||
52-Week Low % Change | 4.14% | |||
Price | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $199.85 | |||
52-Week Low Price | $124.23 | |||
52-Week Low Price (Date) | Feb 19, 2025 | |||
52-Week High Price (Date) | Sep 19, 2024 | |||
Valuation | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 40.77B | |||
Enterprise Value | 43.64B | |||
Price/Earnings (TTM) | 9.14 | |||
Earnings Per Share (TTM) | 14.15 | |||
Earnings Per Share Growth | 1.82% | |||
Price/Earnings To Growth | 5.02 | |||
Price/Sales (TTM) | 1.14 | |||
Price/Book (Q) | 1.65 | |||
Enterprise Value/Revenue (TTM) | 1.19 | |||
Price | $133.96 | |||
Enterprise Value/EBITDA (TTM) | 7.18 | |||
Enterprise Value/EBIT | 7.29 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 323.30M | |||
Dividend Yield | 1.08% | |||
Div. Per Share (Most Recent) | $0.40 | |||
Dividend Per Share (TTM) | $1.40 | |||
Payout Ratio (TTM) | 9.11% | |||
Dividend Per Share (Most Recent) | $0.40 | |||
Company Info | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 817 390 8200 | |||
Address | 1341 Horton Circle Arlington, TX 76011 | |||
Website | www.drhorton.com | |||
Country | United States | |||
Year Founded | 1978 | |||
Profitability | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 16.30% | |||
Profit Margin | 12.68% | |||
Management Effectiveness | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 10.93% | |||
Return on Equity | 19.17% | |||
Income Statement | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 35.82B | |||
Total Revenue (TTM) | 36.69B | |||
Revenue Per Share | $113.48 | |||
Gross Profit (TTM) | 8.95B | |||
EBITDA (TTM) | 6.07B | |||
EBIT (TTM) | 5.98B | |||
Net Income (TTM) | 4.65B | |||
Net Income Avl. to Common (TTM) | 4.65B | |||
Total Revenue Growth (Q YOY) | -1.46% | |||
Earnings Growth (Q YOY) | -10.86% | |||
EPS Diluted (TTM) | 14.15 | |||
EPS Diluted Growth (Q YOY) | -7.45% | |||
Balance Sheet | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 2.81B | |||
Cash Per Share (Q) | $8.70 | |||
Total Current Assets (Q) | 30.94B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 25.46B | |||
Current Ratio (Q) | 6.766 | |||
Book Value Per Share (Q) | $78.53 | |||
Total Assets (Q) | 35.03B | |||
Total Current Liabilities (Q) | 4.57B | |||
Total Debt (Q) | 5.16B | |||
Total Liabilities (Q) | 9.57B | |||
Total Common Equity (Q) | 24.94B | |||
Cash Flow | DHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -208.40M | |||
Cash from Financing (TTM) | -3.06B | |||
Net Change in Cash (TTM) | -275.60M | |||
Levered Free Cash Flow (TTM) | 4.54B | |||
Cash from Operations (TTM) | 2.99B | |||